CardioRenal

Stand C5-B6

2023 Edition

CardioRenal

France

CardioRenal has developed the first in the world connected self-test allowing Heart Failure or Kidney disease patients to monitor their blood potassium at home as easily as diabetic patients measure their glycemia. The device, TENOR,  has been validated in a clinical study in Brussels. TENOR, is currently going through CE clinical trial and has been granted « breakthrough device label » by FDA.  Commercialisation in Europe will start in 2024.